IRS
PDLI

Invictus RG (Singapore)’s PDL BioPharma, Inc. PDLI Stock Holding History

Invictus RG (Singapore)’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-6,900
Closed -$57K – 799
2014
Q1 		$57K Sell
6,900
-30,200
-81% -$259K 0.07% 345
2013
Q4 		$313K Buy
37,100
+8,200
+28% +$69.1K 0.21% 210
2013
Q3 		$230K Buy
28,900
+878
+3% +$7.06K 0.2% 196
2013
Q2 		$216K Buy
+28,022
New +$219K 0.24% 156

Other funds holding PDLI

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invictus RG (Singapore)'s PDLI Position: Q2 2014 in Review

Invictus RG (Singapore) sold out of PDL BioPharma, Inc. (PDLI) in Q2 2014, closing a stake of 6,900 shares — an estimated $57K sold.

Invictus RG (Singapore) first reported a position in PDLI in Q2 2013 and held it in 4 quarters. The position peaked at $313K in Q4 2013. 222 funds tracked by Wall St. Rank hold PDLI as of Q2 2014.

  • Invictus RG (Singapore) reported no remaining PDL BioPharma, Inc. position as of Q2 2014 after selling out during the quarter.
  • Invictus RG (Singapore) sold 6,900 PDL BioPharma, Inc. shares in Q2 2014, an estimated $57K.
  • Invictus RG (Singapore) first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 4 quarters.
  • Invictus RG (Singapore)'s PDL BioPharma, Inc. position peaked at $313K in Q4 2013.
  • 222 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2014.

Based on Invictus RG (Singapore)'s 13F filing for Q2 2014, filed 14 Aug 2014.